Literature DB >> 8152919

The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena.

C Strahl1, E H Blackburn.   

Abstract

The ribonucleoprotein enzyme telomerase is a specialized type of cellular reverse transcriptase which synthesizes one strand of telomeric DNA, using as the template a sequence in the RNA moiety of telomerase. We analyzed the effects of various nucleoside analogs, known to be chain-terminating inhibitors of retroviral reverse transcriptases, on Tetrahymena thermophila telomerase activity in vitro. We also analyzed the effects of such analogs on telomere length and maintenance in vivo, and on vegetative growth and mating of Tetrahymena cells. Arabinofuranyl-guanosine triphosphate (Ara-GTP) and ddGTP both efficiently inhibited telomerase activity in vitro, while azidothymidine triphosphate (AZT-TP), dideoxyinosine triphosphate (ddITP) or ddTTP were less efficient inhibitors. All of these nucleoside triphosphate analogs, however, produced analog-specific alterations of the normal banding patterns seen upon gel electrophoresis of the synthesis products of telomerase, suggesting that their chain terminating and/or competitive actions differ at different positions along the RNA template. The analogs AZT, 3'-deoxy-2',3'-didehydrothymidine (d4T) and Ara-G in nucleoside form caused consistent and rapid telomere shortening in vegetatively growing Tetrahymena. In contrast, ddG or ddI had no effect on telomere length or cell growth rates. AZT caused growth rates and viability to decrease in a fraction of cells, while Ara-G had no such effects even after several weeks in culture. Neither AZT, Ara-G, acycloguanosine (Acyclo-G), ddG nor ddI had any detectable effect on cell mating, as assayed by quantitation of the efficiency of formation of progeny from mated cells. However, AZT decreased the efficiency of programmed de novo telomere addition during macronuclear development in mating cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152919      PMCID: PMC307907          DOI: 10.1093/nar/22.6.893

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

Review 1.  Telomeres and their synthesis.

Authors:  E H Blackburn
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  A mutant with a defect in telomere elongation leads to senescence in yeast.

Authors:  V Lundblad; J W Szostak
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

3.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs.

Authors:  G L Yu; J D Bradley; L D Attardi; E H Blackburn
Journal:  Nature       Date:  1990-03-08       Impact factor: 49.962

Review 4.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

5.  Developmentally programmed healing of chromosomes by telomerase in Tetrahymena.

Authors:  G L Yu; E H Blackburn
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

6.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

Review 7.  Structure and function of telomeres.

Authors:  V A Zakian
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

8.  Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.

Authors:  J E Reardon; W H Miller
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

9.  Recognition and elongation of telomeres by telomerase.

Authors:  E H Blackburn; C W Greider; E Henderson; M S Lee; J Shampay; D Shippen-Lentz
Journal:  Genome       Date:  1989       Impact factor: 2.166

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  27 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  dGTP-dependent processivity and possible template switching of euplotes telomerase.

Authors:  P W Hammond; T R Cech
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

3.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

4.  A novel specificity for the primer-template pairing requirement in Tetrahymena telomerase.

Authors:  H Wang; D Gilley; E H Blackburn
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  Variable telomeric repeat synthesis in Paramecium tetraurelia is consistent with misincorporation by telomerase.

Authors:  M McCormick-Graham; W J Haynes; D P Romero
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

Review 6.  Pancreatic cancer stem cells: fact or fiction?

Authors:  Vikash J Bhagwandin; Jerry W Shay
Journal:  Biochim Biophys Acta       Date:  2009-02-21

7.  Biochemical properties of Trypanosoma cruzi telomerase.

Authors:  Denise P Muñoz; Kathleen Collins
Journal:  Nucleic Acids Res       Date:  2004-09-30       Impact factor: 16.971

8.  Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines.

Authors:  C Strahl; E H Blackburn
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

9.  Computationally designed peptide inhibitors of the ubiquitin E3 ligase SCF(Fbx4).

Authors:  Junglim Lee; Deanne W Sammond; Zeno Fiorini; Jonel P Saludes; Michael G Resch; Bing Hao; Wei Wang; Hang Yin; Xuedong Liu
Journal:  Chembiochem       Date:  2013-02-11       Impact factor: 3.164

10.  Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.

Authors:  Christopher Bryan; Cory Rice; Hunter Hoffman; Michael Harkisheimer; Melanie Sweeney; Emmanuel Skordalakes
Journal:  Structure       Date:  2015-09-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.